kevroc Wednesday, 11/27/19 12:41:51 PM Re: dragon52 post# 92979 Post # of 101290 People that know me here, know that I have stated Bioamber has has sold off the bulk of their tangible assets, and therefore COULD emerge at a greatly reduced valuation. This is WITHOUT any knowledge of LCY investment, KKR involvement, secondary transactions of recapitalization, etc. However, NOL's likely exceeding $400M by the time they sold the plant, patents and multi-billion dollar contracts (which even Judge Pinsonnault stated they hold value) are all factors in a post-liquidation valuation. We lack important data to calculate that potential. Given the recent clues (and I, MYSELF witnessed with my own eyes in my TDA account when LCYGF was a searchable ticker last week), it is not beyond the realm of possibility that BIOAQ shares are now worth 17 cents (after selling tangible assets) and the new JV might issue shares at $4 in order to move directly up to NASDAQ. This is where $4.17 value is derived. Full disclosure: this is ALL SPECULATION, just like everyone else's opinion. But, as I've stated previously... bankrupt and liquidated companies DON'T HAVE OR NEED SO MANY SECRETS. Bankruptcies are VERY public, transparent and embarrassing for a reason. It is the evolution of public shaming of debtors. I don't trust any corporation with confidentiality agreements that survive the closing of court proceedings. I'm not buying whatever they're selling. The truth has to come out some time.